title: Warfarin resistance with poor CYP2C9 activity and CYP2C9*1*2 genotype.
authors.forename: Nese
authors.initials: N
authors.lastname: Dericioglu
authors.forename: Melih O
authors.initials: MO
authors.lastname: Babaoglu
authors.forename: Serap
authors.initials: S
authors.lastname: Saygi
authors.forename: Atila
authors.initials: A
authors.lastname: Bozkurt
authors.forename: Umit
authors.initials: U
authors.lastname: Yasar
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000493:pharmacokinetics*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics* / Q000378:metabolism; D065729:Cytochrome P-450 CYP2C9; D004351:Drug Resistance; D005260:Female; D006801:Humans; D019934:International Normalized Ratio; D011110:Polymorphism, Genetic; D014859:Warfarin / Q000008:administration & dosage / Q000493:pharmacokinetics*
chemical_list: D000925:Anticoagulants; D014859:Warfarin; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases